BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21107604)

  • 21. [Hyper-IgE syndromes].
    He YY; Liu B; Xiao XP
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.
    Freeman AF; Holland SM
    Pediatr Res; 2009 May; 65(5 Pt 2):32R-37R. PubMed ID: 19190525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
    Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
    J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyper IgE syndromes: clinical and molecular characteristics.
    Al-Shaikhly T; Ochs HD
    Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Unexpected Infection in Loss-of-Function Mutations in STAT3: Malignant Alveolar Echinococcosis in Liver.
    Haskologlu S; Dogu F; Gollu Bahadır G; Akyuzluer S; Ciftci E; Altun D; Keles S; Kologlu M; Ikinciogullari A
    Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):667-675. PubMed ID: 33463136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.
    Minegishi Y; Saito M; Tsuchiya S; Tsuge I; Takada H; Hara T; Kawamura N; Ariga T; Pasic S; Stojkovic O; Metin A; Karasuyama H
    Nature; 2007 Aug; 448(7157):1058-62. PubMed ID: 17676033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients.
    Wolach O; Kuijpers T; Ben-Ari J; Gavrieli R; Feinstein-Goren N; Alders M; Garty BZ; Wolach B
    J Clin Immunol; 2014 Feb; 34(2):163-70. PubMed ID: 24452316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
    Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
    Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].
    Alcántara-Montiel JC; Vega-Torres BI
    Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Mutation in SH2 Domain of STAT3 (p.M660T) in Hyper-IgE Syndrome with Sterno-Clavicular and Paravertebral Abscesses.
    Saikia B; Goel S; Suri D; Minz RW; Rawat A; Singh S
    Indian J Pediatr; 2017 Jun; 84(6):494-495. PubMed ID: 28315006
    [No Abstract]   [Full Text] [Related]  

  • 31. Functional characterization of two new STAT3 mutations associated with hyper-IgE syndrome in a Mexican cohort.
    Alcántara-Montiel JC; Staines-Boone T; López-Herrera G; Espinosa-Rosales F; Espinosa-Padilla SE; Hernández-Rivas R; Santos-Argumedo L
    Clin Genet; 2016 Feb; 89(2):217-21. PubMed ID: 26293184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).
    Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Hsieh MY; Huang YC; Kuo HC; Yang KD; Yu HR; Jaing TH; Yang CH
    J Clin Immunol; 2011 Apr; 31(2):272-80. PubMed ID: 21120687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function.
    Giacomelli M; Tamassia N; Moratto D; Bertolini P; Ricci G; Bertulli C; Plebani A; Cassatella M; Bazzoni F; Badolato R
    Eur J Immunol; 2011 Oct; 41(10):3075-84. PubMed ID: 21792878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
    van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
    Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on the hyper-IgE syndromes.
    Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
    Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3 mutations in the hyper-IgE syndrome.
    Holland SM; DeLeo FR; Elloumi HZ; Hsu AP; Uzel G; Brodsky N; Freeman AF; Demidowich A; Davis J; Turner ML; Anderson VL; Darnell DN; Welch PA; Kuhns DB; Frucht DM; Malech HL; Gallin JI; Kobayashi SD; Whitney AR; Voyich JM; Musser JM; Woellner C; Schäffer AA; Puck JM; Grimbacher B
    N Engl J Med; 2007 Oct; 357(16):1608-19. PubMed ID: 17881745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A challenging differential diagnosis in a patient with autosomal dominant STAT3 deficiency.
    Bravo-Queipo-de-Llano B; Bonet D; Del Rosal T; Cámara C; Ruiz de Valbuena M; Pérez A; Grasa CD; Méndez-Echevarría A
    Pediatr Pulmonol; 2023 Feb; 58(2):585-591. PubMed ID: 36267002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups.
    Jiao H; Tóth B; Erdos M; Fransson I; Rákóczi E; Balogh I; Magyarics Z; Dérfalvi B; Csorba G; Szaflarska A; Megarbane A; Akatcherian C; Dbaibo G; Rajnavölgyi E; Hammarström L; Kere J; Lefranc G; Maródi L
    Mol Immunol; 2008 Nov; 46(1):202-6. PubMed ID: 18706697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The signal transducer and activator of transcription 3 at the center of the causative gene network of the hyper-IgE syndrome.
    Minegishi Y
    Curr Opin Immunol; 2023 Feb; 80():102264. PubMed ID: 36435159
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.